IL127423A - A medicinal preparation for giving and penetrating mucous membranes in the nose, mouth and throat - Google Patents

A medicinal preparation for giving and penetrating mucous membranes in the nose, mouth and throat

Info

Publication number
IL127423A
IL127423A IL12742398A IL12742398A IL127423A IL 127423 A IL127423 A IL 127423A IL 12742398 A IL12742398 A IL 12742398A IL 12742398 A IL12742398 A IL 12742398A IL 127423 A IL127423 A IL 127423A
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
liquid pharmaceutical
formulation according
active substance
administration
Prior art date
Application number
IL12742398A
Other languages
English (en)
Hebrew (he)
Other versions
IL127423A0 (en
Original Assignee
Immunotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Sa filed Critical Immunotech Sa
Publication of IL127423A0 publication Critical patent/IL127423A0/xx
Publication of IL127423A publication Critical patent/IL127423A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12742398A 1998-01-15 1998-12-07 A medicinal preparation for giving and penetrating mucous membranes in the nose, mouth and throat IL127423A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800574A FR2773489B1 (fr) 1998-01-15 1998-01-15 Nouvelle composition destinee a la voie oromuqueuse notamment pernasale

Publications (2)

Publication Number Publication Date
IL127423A0 IL127423A0 (en) 1999-10-28
IL127423A true IL127423A (en) 2004-06-20

Family

ID=9521962

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12742398A IL127423A (en) 1998-01-15 1998-12-07 A medicinal preparation for giving and penetrating mucous membranes in the nose, mouth and throat

Country Status (12)

Country Link
US (1) US6326401B1 (ja)
EP (1) EP0938895A1 (ja)
JP (1) JPH11286440A (ja)
KR (1) KR19990067901A (ja)
AU (1) AU743492B2 (ja)
CA (1) CA2256793A1 (ja)
FR (1) FR2773489B1 (ja)
IL (1) IL127423A (ja)
IS (1) IS4942A (ja)
NO (1) NO990120L (ja)
NZ (1) NZ333656A (ja)
ZA (1) ZA9920B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
WO2001005406A1 (fr) * 1999-07-16 2001-01-25 Amato Pharmaceutical Products, Ltd. Preparations de glycyrrhizine pour absorption par voie transmuqueuse
EP1277479A3 (en) * 2001-06-18 2003-01-29 Dsm N.V. Alkali or alkaline earth metal benzoate particles
CN1642576A (zh) * 2002-02-25 2005-07-20 药物发展有限公司 吸收增强剂
US6855332B2 (en) 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
KR100670921B1 (ko) * 2005-07-11 2007-01-19 주식회사마성상사 타크롤리무스 경구투여용 제제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina

Also Published As

Publication number Publication date
KR19990067901A (ko) 1999-08-25
FR2773489B1 (fr) 2001-03-23
EP0938895A1 (fr) 1999-09-01
CA2256793A1 (fr) 1999-07-15
JPH11286440A (ja) 1999-10-19
ZA9920B (en) 1999-07-05
IL127423A0 (en) 1999-10-28
NZ333656A (en) 2000-05-26
NO990120L (no) 1999-07-16
AU1129499A (en) 1999-08-05
NO990120D0 (no) 1999-01-12
US6326401B1 (en) 2001-12-04
AU743492B2 (en) 2002-01-24
IS4942A (is) 1999-07-16
FR2773489A1 (fr) 1999-07-16

Similar Documents

Publication Publication Date Title
EP0524587B1 (en) Therapeutic compositions for intranasal administration which include ketorolac TM
US4788221A (en) Pharmaceutical compositions comprising calcitonin and an absorption-promoting substance
US4548922A (en) Drug administration
US6485706B1 (en) Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
JP3350061B2 (ja) エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
US20030059376A1 (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
WO2002020037A1 (fr) Composition pharmaceutique a administration orale liberee au niveau colique
WO1997006813A1 (fr) Preparation pour muqueuses a base de peptides a activite physiologique
JPH0768149B2 (ja) 鼻腔内投与用調製剤およびその製法
NO338665B1 (no) Doseringssystem med kontrollert frigivning for nasale anvendelser
KR20020059583A (ko) 경비 항경련성 조성물 및 제어 공정
US5407911A (en) Parathyroid hormone-containing emulsion for nasal administration
JPH08245417A (ja) 鼻内投与のための薬学的非無機塩類液剤
US4789660A (en) Insulin administration using methyl and propyl paraben
US6326401B1 (en) Formulation for the oromucosal, in particular pernasal, route
EP0140434B1 (en) Pharmaceutical composition with systemic anticholineesterasic, agonistic-cholinergic and antimuscarinic activity
EP0380047A2 (en) A percutaneous or trans-mucosal absorption enhancer and a percutaneous or trans-mucosal medicine
JP3498041B2 (ja) プラルモレリン含有点鼻用製剤
JP2973077B2 (ja) ビタミンｅ製剤組成物
JP2001505222A (ja) 生物体にペプチド系医薬を導入するための局所用製剤
KR20230035600A (ko) Ghrh 유사체의 저-용량 약제학적 조성물 및 이들의 용도
US20240238270A1 (en) Pharmaceutical formulations of quinolines
IL311565A (en) Oxytocin is linked to the treatment of newborn problems
CN111053742A (zh) 匹伐他汀钙口腔喷雾剂及其制备和使用方法
JPH04295419A (ja) 吸収促進剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees